Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia Gravis
Clinical trial NCT06799247 · RECRUITING
Trial details
- NCT number
- NCT06799247
- Sponsor
- Cartesian Therapeutics
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-06
- Primary completion
- 2026-11-30
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.